A detailed history of Prudential Financial Inc transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 20,232 shares of PACB stock, worth $37,631. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,232
Previous 18,562 9.0%
Holding current value
$37,631
Previous $25,000 36.0%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.2 - $2.17 $2,004 - $3,623
1,670 Added 9.0%
20,232 $34,000
Q1 2024

May 14, 2024

SELL
$3.52 - $9.59 $802 - $2,186
-228 Reduced 1.21%
18,562 $69,000
Q4 2023

Feb 13, 2024

BUY
$5.97 - $10.36 $3,749 - $6,506
628 Added 3.46%
18,790 $184,000
Q3 2023

Nov 13, 2023

SELL
$8.23 - $13.93 $431,334 - $730,071
-52,410 Reduced 74.26%
18,162 $151,000
Q2 2023

Aug 11, 2023

BUY
$9.97 - $14.05 $531,999 - $749,708
53,360 Added 310.02%
70,572 $938,000
Q1 2023

May 12, 2023

BUY
$7.94 - $12.02 $8,416 - $12,741
1,060 Added 6.56%
17,212 $199,000
Q4 2022

Feb 14, 2023

SELL
$5.67 - $11.2 $1,655 - $3,270
-292 Reduced 1.78%
16,152 $0
Q3 2022

Nov 04, 2022

BUY
$3.93 - $8.57 $550 - $1,199
140 Added 0.86%
16,444 $73,000
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $4,940 - $12,818
1,229 Added 8.15%
16,304 $103,000
Q1 2022

May 13, 2022

BUY
$8.43 - $20.9 $2,975 - $7,377
353 Added 2.4%
15,075 $137,000
Q4 2021

Feb 14, 2022

SELL
$19.26 - $30.08 $48,747 - $76,132
-2,531 Reduced 14.67%
14,722 $301,000
Q3 2021

Nov 15, 2021

BUY
$24.86 - $35.02 $23,045 - $32,463
927 Added 5.68%
17,253 $508,000
Q2 2021

Aug 16, 2021

BUY
$22.3 - $36.02 $19,869 - $32,093
891 Added 5.77%
16,326 $571,000
Q1 2021

May 12, 2021

BUY
$26.38 - $51.15 $46,771 - $90,688
1,773 Added 12.98%
15,435 $514,000
Q4 2020

Feb 16, 2021

BUY
$10.5 - $28.5 $16,170 - $43,890
1,540 Added 12.7%
13,662 $354,000
Q3 2020

Nov 16, 2020

SELL
$3.61 - $9.87 $25,955 - $70,965
-7,190 Reduced 37.23%
12,122 $120,000
Q2 2020

Aug 12, 2020

BUY
$2.65 - $4.03 $23,373 - $35,544
8,820 Added 84.06%
19,312 $66,000
Q1 2020

May 12, 2020

SELL
$2.36 - $5.26 $4,012 - $8,942
-1,700 Reduced 13.94%
10,492 $32,000
Q4 2019

Feb 11, 2020

BUY
$4.6 - $5.57 $965 - $1,169
210 Added 1.75%
12,192 $62,000
Q3 2019

Nov 13, 2019

SELL
$4.99 - $6.16 $11,127 - $13,736
-2,230 Reduced 15.69%
11,982 $61,000
Q2 2019

Aug 08, 2019

BUY
$5.92 - $7.41 $9,768 - $12,226
1,650 Added 13.13%
14,212 $0
Q1 2019

May 15, 2019

BUY
$6.8 - $7.4 $1,088 - $1,184
160 Added 1.29%
12,562 $0
Q4 2018

Feb 07, 2019

BUY
$3.99 - $7.82 $8,857 - $17,360
2,220 Added 21.8%
12,402 $91,000
Q3 2018

Nov 07, 2018

SELL
$3.52 - $5.55 $1,513 - $2,386
-430 Reduced 4.05%
10,182 $0
Q2 2018

Aug 13, 2018

BUY
$2.11 - $3.92 $22,391 - $41,599
10,612 New
10,612 $0

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $418M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.